Login / Signup

Lemborexant for insomnia in adults with psychiatric disorders: A 1-week, open-label study.

Taro KishiKenji SakumaMakoto OkuyaNakao Iwata
Published in: PCN reports : psychiatry and clinical neurosciences (2022)
Keyphrases
  • open label
  • clinical trial
  • randomized controlled trial
  • phase ii
  • sleep quality
  • rectal cancer
  • double blind